{{Rsnum
|rsid=11683103
|Chromosome=2
|position=34687783
|Orientation=plus
|GMAF=0.3678
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 48.7 | 40.7 | 10.6
| HCB | 56.9 | 36.5 | 6.6
| JPT | 49.1 | 38.4 | 12.5
| YRI | 12.3 | 39.7 | 47.9
| ASW | 12.3 | 50.9 | 36.8
| CHB | 56.9 | 36.5 | 6.6
| CHD | 58.7 | 36.7 | 4.6
| GIH | 60.4 | 32.7 | 6.9
| LWK | 16.4 | 58.2 | 25.5
| MEX | 51.7 | 37.9 | 10.3
| MKK | 26.3 | 50.0 | 23.7
| TSI | 46.1 | 45.1 | 8.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11683103
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363813
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11683103
|overall_frequency_n=67
|overall_frequency_d=128
|overall_frequency=0.523438
|n_genomes=41
|n_genomes_annotated=0
|n_haplomes=59
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}